Extracellular ATP activates cell-surface metabotropic and ionotropic nucleotide (P2) receptors in vascular, neural, connective, and immune tissues. These P2 receptors mediate a wealth of physiological processes, including nitric oxide-dependent vasodilation of vascular smooth muscle and fast excitatory neurotransmission in sensory afferents. Although ATP is now recognized as a signaling molecule, the cellular and molecular mechanisms underlying its actions have been difficult to study due to the absence of selective P2 receptor antagonists and cloned receptor genes. Nonetheless, five mammalian P2 receptor subtypes have been tentatively assigned based solely on agonist specificity and signaling properties.
Here we report the cloning of a mouse cDNA encoding a P2 receptor that shares striking homology with several G proteincoupled peptide receptors. When expressed in Xenopus laevis oocytes, the cloned receptor resembles a metabotropic P2U receptor; activation by either ATP or UTP elicits the mobilization of intracellular calcium. mRNA encoding the P2U purinergic receptor is found in neural and nonneural tissues.
There is considerable evidence suggesting that ATP functions as an extracellular signaling molecule in neural and nonneural mammalian tissues (1, 2) . In central and peripheral synapses, ATP mediates fast excitatory neurotransmission (3, 4) . In the autonomic nervous system, ATP is a major purinergic cotransmitter that is often colocalized in secretory vesicles with norepinephrine or acetylcholine (5, 6) . In the vascular system, aggregating platelets secrete ATP and ADP, which stimulate the release of nitric oxide and other vasodilators from the endothelium (7) . In the immune system, ATP modulates macrophage phagocytosis (8) and mast cell degranulation (9) . In the human airway epithelium, ATP stimulates transepithelial ion transport (10) , an effect that may underlie the therapeutic effect of ATP and UTP in the treatment of cystic fibrosis-related lung disease (11) .
It has been postulated that these responses to extracellular ATP are mediated by specific plasma membrane receptors, called P2 purinergic receptors (12, 13) . Based on agonist selectivity and signaling properties, five subclasses of P2 receptor have been tentatively defined: three subclasses of receptors (P2T, P2U, and P2y) that are believed to signal through G proteins, one subclass (P2X) that is believed to be a ligand-gated cation channel, and one subclass (P2z) that is present on mast cells, macrophages, and fibroblasts, but whose signaling mechanism is less well understood (1, (14) (15) (16) . G protein-coupled P2 receptors are found in numerous cultured cell lines, where they have been shown to activate signal transduction systems that involve the breakdown of membrane phospholipids and the elevation of cytoplasmic free Ca2+ (17, 18) . Ionotropic P2X receptors carry Na+, K+, and Ca2+ currents and appear to be predominantly expressed in neural and neuromuscular tissues (16) .
A more complete characterization ofthis putative family of P2 purinergic receptors has been hampered by the complete lack of specific P2 receptor antagonists, radioligands, and cloned receptor cDNAs. To circumvent this difficulty, we have used a Xenopus laevis oocyte expression cloning strategy (19, 20) to isolate a cDNA encoding a functional P2U receptor from NG108-15 neuroblastoma x glioma hybrid cells.t We have examined the agonist selectivity, signaling properties, species origin, and tissue distribution of the cloned P2U receptor.
EXPERIMENTAL PROCEDURES
Expression Cloning. NG108-15 cells were grown in monolayer culture (21) , total cellular RNA was isolated by the guanidine thiocyanate method (22) , and poly(A)+ RNA was selected on oligo(dT)-cellulose. A directional cDNA library (2 x 106 recombinants) was constructed in pCCM6XL as described (23) . pCCM6XL is a derivative of pCDM6XL in which a 778-bp Taq I fragment containing a gene encoding chloramphenicol acetyltransferase was inserted into the BstBI site of the supF gene. Initially, the NG108-15 cDNA library was subdivided into 10 pools of 2 x 105 clones. Templates for in vitro transcription were prepared by linearizing plasmid DNA isolated from these pools with Not I. Complementary RNA (cRNA) transcripts were synthesized using SP6 RNA polymerase as described (20) .
X. laevis oocytes were surgically isolated (24) and enzymatically defolliculated by incubation with 2 mg of collagenase per ml for 2 hr at room temperature. Defolliculated oocytes were washed five times with modified Barth's solu- tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. L14751).
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serum albumin) and incubated for 3 hr at room temperature in 0. RNA from NG108-15 cells, bath-applied ATP or UTP (1 mM) evoked inward currents (between 20 and 200 nA) that are typical of the activation of phospholipase C-coupled receptors (not shown). To identify a cDNA encoding the P2R, pools of 2 x 105 individual clones from a NG108-15 cDNA library were transcribed in vitro and the resultant cRNA was injected into oocytes. The pool that rendered the oocytes responsive to ATP or UTP was progressively subdivided to obtain a single plasmid clone called pP2R (Fig. 1) .
Predicted Structure of P2R. Sequence analysis revealed that the cloned P2R cDNA has a 1119-bp open reading frame (Fig. 2) , 269 bp of 5' untranslated sequence, and -1 kb of 3' untranslated sequence. The largest open reading frame encodes a putative protein of 373 amino acids with a predicted relative molecular mass of 42,172. Analysis of the deduced amino acid sequence suggests that the protein contains a small N-terminal extracellular domain, seven hydrophobic transmembrane domains, and a large C-terminal intracellular domain. There are two consensus N-linked glycosylation sites near the N terminus and several potential phosphorylation sites near the C terminus (Fig. 2) . The only site that resembles a consensus nucleotide-binding motif
27] is comprised of residues 18-24 (GDELGYK) located in the putative N-terminal extracellular domain.
Sequence comparisons (Fig. 3) indicate that the cloned P2R is a member of the G protein-coupled receptor superfamily. The predicted amino acid sequence of the cloned P2R contains a number of highly conserved amino acids (Asn-51, Asp-79, Leu-81, Arg-131, Pro-167, and Pro-303) that are believed to be important for the function of G protein-coupled receptors (33) . The cloned receptor is most similar to receptors for thrombin (25% identity), platelet-activating factor (25% identity), angiotensin II (22% identity), interleukin 8 (23% identity), and GPRN1, a putative vasoactive intestinal peptide receptor (21% identity). The cloned receptor is substantially less similar (<12% identity) to G proteincoupled receptors for adenosine and cAMP.
THROMBIN L NTT CHDV L N E TLEGYYA F S A V F L S T CYVS CL PAF K A G S G NI T R C F E H Y E K G00K PL II H C VIF V FL LI LFC
Functional Characterization of the Cloned P2R. Functional characterization of the cloned receptor using transfected mammalian cells was hindered by the presence of endogenous P2 receptors and ubiquitous nucleotide-binding proteins and the absence of selective high-affinity radioligands. We therefore examined the pharmacology of the cloned receptor in Xenopus oocytes injected with pP2R cRNA transcripts. In voltage-clamped oocytes expressing the cloned P2R, inward currents (,s500 nA) were elicited by bath application of50 AuM ATP, UTP, or ATP[yS] but not 50 AM 2-MeSATP, AMP-PCP, ADP, AMP-CPP, or adenosine (Fig. 1) . Agonist stimulation of phospholipase C-coupled receptors in oocytes activates endogenous calcium-dependent chloride channels that carry inward currents (34). Thus, ATP also elicited an increase in the rate of 45Ca2+ efflux (Fig. 4) , indicative of an increase in intracellular free Ca2+ (35) . The order of agonist (Fig. 4) . In uninjected or water-injected oocytes, none ofthe compounds reproducibly evoked inward currents or enhanced the rate of 45Ca2+ efflux (not shown). In these control oocytes, ATP and UTP occasionally induced inward currents (typically <20 nA), which may be due to the activation of a P2 receptor endogenous to the oocytes. Of the subtypes of P2 receptors that have been tentatively assigned, this agonist specificity is most similar to that of the P2U (nucleotide) receptor subtype, for which ATP and UTP are more potent agonists than 2-MeSATP (15). In NG108-15 cells, ATP and UTP activate an endogenous P2u receptor that mobilizes intracellular Ca2+ (36, 37) .
ATP hydrolysis does not appear to be necessary for receptor activation since the cloned P2R (Fig. 1) Species Type and Tissue Distribution of the Cloned P2R. Polymerase chain reaction (PCR) and Northern blot analyses revealed that the receptor is derived from the mouse N18TG2 neuroblastoma and not the rat C6 glioma parent cell line. Two oligonucleotide primers corresponding to positions 277-306 and 646-675 of the P2R cDNA (Fig. 2) were used to amplify total mouse or rat genomic DNA by standard PCR. A PCR product corresponding to an =0.4-kb region of the P2 receptor could be amplified from pP2R, rat genomic or mouse genomic DNA templates. Amplification at higher stringency, however, yielded an =0.4-kb PCR product only with pP2R and mouse genomic DNA (not shown). When PCR products of the lower stringency reactions were digested with Ava I, BstEII, Eae I, Pst I, or Sma I and resolved on a 1.5% agarose gel, the restriction pattern of the mouse PCR product was identical to that of the pP2R PCR product, whereas the restriction map of the rat PCR product differed at one Ava I and one Sma I site (not shown). In addition, on Northern blots, an -2.4-kb RNA species was detected in NG108-15 cells and mouse N18TG2 cells, whereas an -3.0-kb RNA species was detected in rat C6 glioma cells (Fig. 5) . Taken together, these observations demonstrate that the cloned P2R cDNA is of murine origin.
Northern blot analysis revealed that mRNA encoding the P2R is widely distributed in mouse tissues. An %2.4-kb RNA species was detected in spleen, testes, kidney, liver, lung, heart, and brain (Fig. 5 ). An -2.4-kb RNA species was also detected in mouse NlE-115 neuroblastoma cells.
DISCUSSION
We have isolated a cDNA clone encoding the first member of what, to our knowledge, is likely to be a new gene family of nucleotide receptors. Our results now provide molecular genetic evidence for the existence of plasma membrane receptors for ATP. The cloned P2R has predicted structural features that are characteristic of most known G proteincoupled receptors: an N-terminal extracellular domain with two consensus sites for N-linked glycosylation, seven hydrophobic putative transmembrane a-helices, and a large C-terminal intracellular domain containing several consensus phosphorylation sites. A surprising finding is that the cloned P2R is considerably more homologous to G protein-coupled peptide receptors than to receptors for the structurally related ligands adenosine and cAMP.
Five mammalian P2 receptor subtypes have been tentatively assigned based on agonist selectivity and signaling properties (2, 15) . The characteristics of the cloned P2R are most similar to those of the P2u receptor subtype (15) . The cloned P2R and the endogenous P2U receptor expressed in NG108-15 cells (37) are activated by ATP or UTP and both couple to a signal transduction system involving increases in cytoplasmic free Ca2+. Our findings demonstrate that the pharmacological profile of the P2U site can be attributed to a single gene product. This direct relationship has proven difficult to establish due to the lack of subtype-selective pharmacological or molecular probes.
P2 receptors have been implicated in the regulation of neurotransmission, vascular tone, wound healing, inflammation, muscle contraction, immune responses, pulmonary function, and cell growth (1, 2, 7, 16) . Ca2+-linked P2 receptors that respond to ATP or UTP are expressed in cell lines 1 derived from many different sources, including neural, muscular, vascular, connective, and epithelial tissues. Consistent with the idea that we have cloned a ubiquitous P2 receptor, P2R mRNA is expressed in all mouse tissues that we have analyzed. Presumably, P2R-mediated changes in intracellular free Ca2+ or other cytoplasmic second messenger systems promote tissue-or cell-type-specific physiological responses.
ATP has been demonstrated to act as a rapid excitatory neurotransmitter in the nervous system and as a hormone in many nonneural tissues (1, 2) . Cloning of this P2 receptor provides a crucial reagent for examining the structure, function, and expression of members of the ATP receptor family.
